Surgery, Emergency and Critical Care

Sarah le Jeune, DVM, CVA, Diplomate ACVS

Clinical Equine Emergency Surgery and Critical Care

Dr. le Jeune is an equine emergency surgeon with a strong interest in acupuncture. Research interests include studies investigating the effectiveness of acupuncture and clinical studies on various facets of equine gastro-intestinal diseases and other equine surgical conditions.

Please visit Dr. le Jeune's website at: http://faculty.vetmed.ucdavis.edu/faculty/sslejeune/

Ronald Li, DVM, MVetMed, DACVECC

Department of Surgical and Radiological Sciences 

(See also: Biochemistry/Cellular Biology, Immunology/Infectious Diseases)

The Li Laboratory focuses on the study of hemostasis and thrombosis in various diseases.  We are currently investigating the role of platelets in thrombosis and inflammation during bacterial sepsis in dogs.  We are also investigating the formation of neutrophil extracellular traps (NETs) in horses with sepsis.  Particularly, we are interested in assessing the expression and function of Toll-like receptors on platelets during sepsis and how they mediate interactions with neutrophils and NET formation.  Our other research focus includes the pharmacogenetics of antiplatelet therapy in cats with hypertrophic cardiomyopathy.   

Opportunities for STAR projects involve our current studies in platelet activation and platelet/neutrophil interaction in NET formation in canine and equine sepsis.  Please contact Ronald Li at rhli@ucdavis.edu for more information.

Aijun Wang, PhD

UC Davis Medical Center, Department of Surgery (see also: Translational Research, Orthopedics, Biochemistry)

My name is Aijun Wang. I am an assistant professor at the Department of Surgery, School of Medicine. My research interests center on engineering stem cells and biomaterials to develop novel regenerative medical therapies, especially surgical treatments for congenital anomalies. Since my employment as Co-Director of the Surgical Bioengineering Laboratory and an Assistant Professor at the University of California Davis School of Medicine in 2012, my lab has successfully combined tissue-engineering technologies with the most advanced fetal intervention, and developed novel biomaterial and stem cell-based treatments (including nanofibrous materials, fetal membrane, decelluarized extracellular matrix, iPSC-derived stem cells, placenta-derived stem cells) for devastating structural and genetic birth defects, such as spina bifida, hemophilia and congenital diaphragmatic hernia. Currently, we are extensively using the mouse, rat, guinea pig, rabbit and sheep experimental models to develop novel regenerative therapies. We are also adapting these novel therapies we developed in the lab for the treatment of naturally occurring diseases in companion animals.

Please visit Dr. Wang’s website at http://www.ucdmc.ucdavis.edu/surgery/research/wang.html or the  website  for  the  Surgical Bioengineering Laboratory at  http://www.ucdmc.ucdavis.edu/surgery/research/index.html

Contact Dr. Wang: aawang@ucdavis.edu.